Péter Keglevich

417 total citations
32 papers, 312 citations indexed

About

Péter Keglevich is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Péter Keglevich has authored 32 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 18 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Péter Keglevich's work include Alkaloids: synthesis and pharmacology (18 papers), Cancer Treatment and Pharmacology (8 papers) and Chemical synthesis and alkaloids (8 papers). Péter Keglevich is often cited by papers focused on Alkaloids: synthesis and pharmacology (18 papers), Cancer Treatment and Pharmacology (8 papers) and Chemical synthesis and alkaloids (8 papers). Péter Keglevich collaborates with scholars based in Hungary and Iraq. Péter Keglevich's co-authors include László Hazai, Csaba Szántay, György Kalaus, Miklós Dékány, Csaba Szántay, Csaba Szántay, Péter Ábrányi‐Balogh, István Zupkó, Attila Hunyadi and Zoltán Bánóczi and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Tetrahedron Letters.

In The Last Decade

Péter Keglevich

31 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Keglevich Hungary 10 160 124 113 80 53 32 312
László Hazai Hungary 11 180 1.1× 151 1.2× 132 1.2× 90 1.1× 54 1.0× 38 338
Katsuhiko Gato Japan 7 178 1.1× 52 0.4× 50 0.4× 79 1.0× 29 0.5× 10 335
Hiroki Gunji Japan 14 231 1.4× 58 0.5× 215 1.9× 125 1.6× 36 0.7× 23 434
Fuzhuo Li China 12 271 1.7× 77 0.6× 212 1.9× 129 1.6× 22 0.4× 18 482
Mazhar Iqbal United Kingdom 10 251 1.6× 26 0.2× 80 0.7× 36 0.5× 32 0.6× 20 345
Chisato Tode Japan 11 92 0.6× 45 0.4× 128 1.1× 45 0.6× 10 0.2× 38 340
Jake A. Yorke United Kingdom 8 58 0.4× 270 2.2× 164 1.5× 30 0.4× 69 1.3× 8 358
Valentin S. Enev Austria 14 399 2.5× 45 0.4× 129 1.1× 102 1.3× 45 0.8× 41 539
К. Ф. Турчин Russia 13 219 1.4× 43 0.3× 200 1.8× 62 0.8× 41 0.8× 90 404
Tanya T. Ransom United States 8 160 1.0× 36 0.3× 156 1.4× 101 1.3× 14 0.3× 9 357

Countries citing papers authored by Péter Keglevich

Since Specialization
Citations

This map shows the geographic impact of Péter Keglevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Keglevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Keglevich more than expected).

Fields of papers citing papers by Péter Keglevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Keglevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Keglevich. The network helps show where Péter Keglevich may publish in the future.

Co-authorship network of co-authors of Péter Keglevich

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Keglevich. A scholar is included among the top collaborators of Péter Keglevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Keglevich. Péter Keglevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keglevich, Péter, Renáta Minorics, Gitta Schlosser, et al.. (2024). Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments. International Journal of Molecular Sciences. 25(13). 7428–7428. 1 indexed citations
2.
Hazai, László, et al.. (2024). Flavone Hybrids and Derivatives as Bioactive Agents. Applied Sciences. 14(3). 1039–1039. 1 indexed citations
3.
Keglevich, Péter, et al.. (2024). Novel Piperazine Derivatives of Vindoline as Anticancer Agents. International Journal of Molecular Sciences. 25(14). 7929–7929. 3 indexed citations
4.
Keglevich, Péter, et al.. (2023). Synthesis and In Vitro Anticancer Evaluation of Chrysin Containing Hybrids and Other Chrysin Derivatives. Periodica Polytechnica Chemical Engineering. 67(2). 316–336. 2 indexed citations
5.
Keglevich, Péter, et al.. (2021). New Anticancer Vinca Alkaloids in the Last Decade - A Mini-Review. Current Organic Chemistry. 25(10). 1224–1234. 9 indexed citations
6.
Keglevich, Péter, et al.. (2021). Synthesis of Novel Vindoline‐Chrysin Hybrids. Chemistry & Biodiversity. 19(1). e202100725–e202100725. 9 indexed citations
7.
Keglevich, Péter, et al.. (2020). Synthesis and In Vitro Anticancer Evaluation of Novel Chrysin and 7-Aminochrysin Derivatives. Molecules. 25(4). 888–888. 22 indexed citations
8.
Dékány, Miklós, Csaba Szántay, Attila Hunyadi, et al.. (2020). Synthesis and Cytotoxic Activity of New Vindoline Derivatives Coupled to Natural and Synthetic Pharmacophores. Molecules. 25(4). 1010–1010. 14 indexed citations
9.
Keglevich, Péter, et al.. (2020). Results in Chemistry of Natural Organic Compounds. Synthesis of New Anticancer Vinca Alkaloids and Flavone Alkaloids. Chemistry. 2(3). 714–726. 10 indexed citations
10.
Dékány, Miklós, et al.. (2019). Synthesis of vinca alkaloid–triphenylphosphine derivatives having potential antitumor effect. Phosphorus, sulfur, and silicon and the related elements. 194(4-6). 606–609. 8 indexed citations
11.
Bánóczi, Zoltán, Ildikó Szabó, Ivan Ranđelović, et al.. (2018). The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell‐penetrating peptide. Journal of Peptide Science. 24(10). e3118–e3118. 16 indexed citations
12.
Keglevich, Péter, et al.. (2016). The Chemistry of Galanthamine. Classical Synthetic Methods and Comprehensive Study on its Analogues. Mini-Reviews in Medicinal Chemistry. 16(18). 1450–1461. 7 indexed citations
13.
Keglevich, Péter, et al.. (2016). Studies on the mechanism of quaternization of the catharanthine part of vinblastine and vincristine. Tetrahedron Letters. 57(15). 1672–1677. 2 indexed citations
14.
Hegedűs, László, Csaba Szántay, Miklós Dékány, et al.. (2016). Anomalous Products in the Halogenation Reactions of Vinca Alkaloids. Current Organic Chemistry. 20(24). 2639–2646. 3 indexed citations
15.
Keglevich, Péter, et al.. (2015). Cyclopropanation of Some Alkaloids. Periodica Polytechnica Chemical Engineering. 59(1). 3–15. 5 indexed citations
16.
Milen, Mátyás, Péter Slégel, Péter Keglevich, et al.. (2015). Efficient synthesis of N b -thioacyltryptamine derivatives by a three-component Willgerodt–Kindler reaction, and their transformation to 1-substituted-3,4-dihydro-β-carbolines. Tetrahedron Letters. 56(42). 5697–5700. 6 indexed citations
17.
Szántay, Csaba, Péter Keglevich, László Hazai, et al.. (2013). Synthesis and in vitro Antitumor Effect of New Vindoline Derivatives Coupled with Amino Acid Esters. Heterocycles. 87(11). 2299–2299. 12 indexed citations
18.
Nyitrai, Gabriella, Orsolya Kékesi, Péter Keglevich, et al.. (2011). Assessing toxicity of polyamidoamine dendrimers by neuronal signaling functions. Nanotoxicology. 6(6). 576–586. 14 indexed citations
19.
Szántay, Csaba, et al.. (2011). A New Derivative of Galanthamine: Methylene Insertion into the Aromatic Ring in Place of Cyclopropanation. Heterocycles. 84(2). 1171–1171. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026